Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

More than a Genetic Code: Epigenetics of Lung Fibrosis
Krystian Bartczak, Adam Białas, Mateusz Kotecki, et al.
Molecular Diagnosis & Therapy (2020) Vol. 24, Iss. 6, pp. 665-681
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
Qianru Mei, Zhe Liu, He Zuo, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 210
Epigenetic regulation in fibrosis progress
Taixiong Xue, Xingyu Qiu, Hongyao Liu, et al.
Pharmacological Research (2021) Vol. 173, pp. 105910-105910
Closed Access | Times Cited: 72
Biomarkers in idiopathic pulmonary fibrosis: Current insight and future direction
Zhen Zheng, Fei Peng, Yong Zhou
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2024) Vol. 2, Iss. 2, pp. 72-79
Open Access | Times Cited: 9
Silicosis: from pathogenesis to therapeutics
Yang Bi-jun, Xiaoman Liu, Cheng Peng, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
A particle of concern: explored and proposed underlying mechanisms of microplastic-induced lung damage and pulmonary fibrosis
R. K. Gautam, Laltanpuia, Nishant Singh, et al.
Inhalation Toxicology (2025), pp. 1-17
Closed Access | Times Cited: 1
Molecular pathways and role of epigenetics in the idiopathic pulmonary fibrosis
Varalakshmi Velagacherla, Chetan Hasmukh Mehta, Yogendra Nayak, et al.
Life Sciences (2022) Vol. 291, pp. 120283-120283
Closed Access | Times Cited: 36
The Genetic and Epigenetic Footprint in Idiopathic Pulmonary Fibrosis and Familial Pulmonary Fibrosis: A State-of-the-Art Review
Claudio Tirelli, Chiara Pesenti, Monica Miozzo, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 3107-3107
Open Access | Times Cited: 31
Advances in cellular senescence in idiopathic pulmonary fibrosis (Review)
Shan Han, Qiangwei Lu, Xiaoqiu Liu
Experimental and Therapeutic Medicine (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 17
Curcumin regulates pulmonary extracellular matrix remodeling and mitochondrial function to attenuate pulmonary fibrosis by regulating the miR-29a-3p/DNMT3A axis
Meng‐Hsuan Cheng, Hsuan‐Fu Kuo, Chia-Yuan Chang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116572-116572
Open Access | Times Cited: 7
Epigenetic Mechanisms in Parenchymal Lung Diseases: Bystanders or Therapeutic Targets?
Edibe Avcı, Pouya Sarvari, Rajkumar Savai, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 546-546
Open Access | Times Cited: 23
Mesenchymal cells in the Lung: Evolving concepts and their role in fibrosis
Giovanni Ligresti, Ahmed Raslan, Jeongmin Hong, et al.
Gene (2023) Vol. 859, pp. 147142-147142
Open Access | Times Cited: 15
The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis
Di Yang, Peng Xu, Haibi Su, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Epigenetic Control of Alveolar Macrophages: Impact on Lung Health and Disease
Nirmal Parajuli, Kalpana Subedi, Xzaviar Kaymar Solone, et al.
Cells (2025) Vol. 14, Iss. 9, pp. 640-640
Open Access
Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosis
Manas Sehgal, Sharayu Manish Jakhete, Amruta Ganesh Manekar, et al.
Heliyon (2022) Vol. 8, Iss. 8, pp. e09773-e09773
Open Access | Times Cited: 14
High-Fat Diet Related Lung Fibrosis-Epigenetic Regulation Matters
Juntang Yang, Chenxi Liang, Lulu Liu, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 558-558
Open Access | Times Cited: 8
Epigenetics Approaches toward Precision Medicine for Idiopathic Pulmonary Fibrosis: Focus on DNA Methylation
Wiwin Is Effendi, Tatsuya Nagano
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1047-1047
Open Access | Times Cited: 8
ING5 overexpression upregulates miR-34c-5p/Snail1 to inhibit EMT and invasion of lung cancer cells
Jiong Yang, Xinli Liu, Yang Sun, et al.
Acta Biochimica et Biophysica Sinica (2023) Vol. 55, Iss. 5, pp. 809-817
Open Access | Times Cited: 7
Dextromethorphan inhibits collagen and collagen-like cargo secretion to ameliorate lung fibrosis
Muzamil Majid Khan, George Galea, Juan E. Jung, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 778
Open Access | Times Cited: 2
Lung fibrosis in sarcoidosis. Is there a place for antifibrotics?
Karol Bączek, Wojciech Piotrowski
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Markers of Rejection of A Lung Allograft: State of the Art
Tharushi Ayanthika de Silva, Joanne Voisey, Peter Hopkins, et al.
Biomarkers in Medicine (2022) Vol. 16, Iss. 6, pp. 483-498
Open Access | Times Cited: 9
Endogenous Long Pentraxin 3 Exerts a Protective Role in a Murine Model of Pulmonary Fibrosis
Federica Maccarinelli, Mattia Bugatti, Ander Churruca Schuind, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 12
Creating an Optimal In Vivo Environment to Enhance Outcomes Using Cell Therapy to Repair/Regenerate Injured Tissues of the Musculoskeletal System
David A. Hart, Norimasa Nakamura
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1570-1570
Open Access | Times Cited: 8
Association of Fetal Lung Development Disorders with Adult Diseases: A Comprehensive Review
Alexey V. Yaremenko, Nadezhda A. Pechnikova, Κonstantinos Porpodis, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 368-368
Open Access | Times Cited: 1
Aging Lung: Molecular Drivers and Impact on Respiratory Diseases—A Narrative Clinical Review
Paweł Górski, Adam Białas, Wojciech Piotrowski
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1480-1480
Open Access | Times Cited: 1
5-Aza-2′-Deoxycytidine (5-Aza-dC, Decitabine) Inhibits Collagen Type I and III Expression in TGF-β1-Treated Equine Endometrial Fibroblasts
Joana Alpoim‐Moreira, Anna Szóstek‐Mioduchowska, Magda Słyszewska, et al.
Animals (2023) Vol. 13, Iss. 7, pp. 1212-1212
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top